美国药物监督管理局批准的呼吸道清除装置Vest APX用于慢性肺部疾病. Baxter International launches FDA-cleared Vest APX airway clearance device for chronic lung conditions.

巴克斯特国际公司为患有慢性肺病的成人和儿童推出了Vest 高级肺部经验(Vest APX)系统,这是下一代的空气通关装置。 Baxter International has launched the Vest Advanced Pulmonary Experience (Vest APX) System, a next-generation airway clearance device for adults and children with chronic lung conditions. 它最近获得了 FDA 510（k） 许可，采用高频胸壁振荡技术，有助于清除粘液。 Recently granted FDA 510(k) clearance, it features high-frequency chest wall oscillation technology to help clear mucus. 该系统更舒适、便携和方便用户,有一个较小的控制单位,并通过巴克斯特的CARE Connex方案提供支助。 The system is more comfortable, portable, and user-friendly, with a smaller control unit and support through Baxter's CARE Connex program.